The roots of Novartis reach back more than 250 years, to the chemical and scientific traditions that helped shape modern healthcare. Thirty years after its creation, a legacy of discovery and curiosity continues to guide its pursuit of new possibilities for patients.

1 in 5 Americans lives with an autoimmune disease, yet many have no or very limited treatment options. Christy Siegel, SVP and TA Head, Immunology, Novartis US, shares how we aim to change that.

Colin works on a cryo-electron microscope the size of a room using a process that earned a team of scientists a Nobel Prize. Learn how his work is advancing the ways we treat disease.

Findings from the Breast Health & Experience Index reveal many women diagnosed with breast cancer want earlier, more honest conversations about the possibility of recurrence to help them feel more informed and empowered.